Camfil Farr Opens Expanded Facility for the Manufacture of Containment Products
RIVERDALE, N.J., August 2003 - Camfil Farr has opened a new 130,000-square-foot facility in Washington, N.C., for the manufacture of filter containment systems. Four times the size of the former plant, the facility includes expanded space for research and development activities as well as production. It is the new home for the company's rapidly growing Safety and Protection Division, which has recently added staff in engineering, sales and manufacturing.
The Washington, N.C. facility will produce a wide range of specialized products including bag-in/bag-out air filtration systems for the containment of hazardous airborne contaminants. These products have long been used in nuclear facilities, hospitals, chemical and biomedical plants, laboratories and other locations requiring the utmost safety and protection. Now many government buildings, command centers and strategic buildings are also being equipped with these highly customized systems as a safeguard against the threat of bioterrorism.
Camfil Farr has the unique capability to manufacture all of its containment system components in-house - from bags to filter elements to housings. This approach provides customers with optimum compatibility and single-source responsibility. In addition, every component undergoes a Camfil Farr Quality Assurance Procedure that exceeds virtually any published procedure or standard, notably ASME NQA-1.
In addition to bag-in/bag-out systems, the Washington facility will also manufacture a full line of high efficiency gas adsorbers (HEGA filters) and PharmaSeal ducted ceiling modules for cleanroom applications.
A leader in clean air solutions, Camfil Farr manufactures and markets air filtration products for comfort air, clean process, safety and protection, and transportation applications. It is one of the air filtration industry's few global suppliers, with 20 strategically located manufacturing facilities and sales representation in more than 60 countries around the world.
Source: Camfil Farr
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
